| 查看: 399 | 回复: 0 | |||
[交流]
“Metabolite signaling causing fatty liver disease”
|
|
A postdoctoral fellow position available in “Metabolite signaling causing fatty liver disease” A postdoctoral position for 2 years is available in the laboratory of Philipp Kaldis at Lund University (https://portal.research.lu.se/en/persons/philipp-kaldis). We are using a combination of omics-approaches (RNAseq, ChIPseq, metabolomics, and lipidomics) and mouse genetics to study how metabolism is re-wired during liver disease and diabetes as a function of cell division (eLife 9:e63835, Developmental Cell 47:425-438; Hepatol Int. 14:463-474; PLOS Genetics 16:e1009084, for a summary of our current work see: https://researchoutreach.org/art ... ion-liver-beyond/). We are looking for a highly motivated postdoctoral fellow that can drive research projects, wants to further her/his career, and will be collaborating with multiple research groups internationally. We are located at the Lund University Diabetes Center (LUDC), Clinical Research Centre (CRC) in Malmö, Sweden (across the bridge from Copenhagen), which is an excellent environment to do research with many research and clinical groups close by. Requirements: PhD in Cell, Molecular Biology, Biochemistry, or Genetics (less than 3 years since graduation) Experience in metabolism, liver biology, or mouse genetics Enthusiastic, passionate, and hard working Proficient in laboratory techniques like qPCR, cloning, WB, and cell culture Able to communicate in English Interested applicants should send a CV, publication list, a brief description of research interests and experience, and three confidential letters of reference to: Prof. Philipp Kaldis philipp.kaldis@med.lu.se |
回复此楼» 猜你喜欢
苯并呋咱全解析：NBD 荧光衍生化试剂母核的化学特性与实验室应用
已经有0人回复
-
生物质炭与活化剂氢氧化钾混合注意事项
已经有0人回复
-
化学工程及工业化学论文润色/翻译怎么收费?
已经有53人回复
-
科研人必读：新一代 KRAS G12C 抑制剂 Olomorasib 的研究进展
已经有0人回复
-
BT-11（Omilancor）研究化合物全解析：从分子结构到实验应用要点
已经有0人回复
-
富马酸贝达喹啉：二芳基喹啉类工具化合物的化学特征
已经有0人回复
-
BT投稿with editor状态快两周了，正常吗
已经有25人回复
-
Silevertinib（BDTX-1535）结构拆解：炔基双环片段为何成为合成瓶颈
已经有0人回复
-
RO4929097 解析：双苯并氮杂䓬骨架与 Notch 通路实验设计要点
已经有0人回复
-
分子量 1157 的 PROTAC 怎么配不析出：SGK3-PROTAC1 的溶解、分装与图谱复核
已经有0人回复
-
logP 6.1 的羧酸怎么配母液：GSK 650394 的溶解窗口与稀释顺序
已经有0人回复
